However, evidence suggests neither of the first two scenarios are correct
While results vary, many patients experience: Weeks 14: Reduced appetite and improved portion control Weeks 48: Noticeable fat loss and increased consistency 8+ weeks: Continued weight loss and metabolic improvements Consistency and provider-guided adjustments are key to long-term results
PlexusDx compounded GLP-1 optionsincluding semaglutide ($189/mo) and tirzepatide ($289/mo)are available through licensed 503A pharmacies once a qualified provider determines medical appropriateness for your individual situation
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around your individual GLP-1 and peptide pathway predispositionsspecifically variants in GLP1R, GIPR, FTO, and MC4R genes
When you compare Tirzepatide and Semaglutide head-to-head on side effects, it's just no contest, and we know exactly why this is